Product Details
| Product Name: Ilaprazole Nitroso Impurity 123 | Min. Order: 10mg |
| Purity: 99%+ HPLC | Supply Ability: 1000 |
| Release date: 2025/07/31 | |
| Molecular formula: C19H17N5O3S |
Ilaprazole Nitroso Impurity 123;C21H21N3O9

Product Information
Product Number: I030123
English Name: Ilaprazole Nitroso Impurity 123
English Alias: 2-(((4-methoxy-3-methylpyridin-2-yl)methyl)sulfinyl)-1-nitroso-6-(1H-pyrrol-1-yl)-1H-benzo[d]imidazole
CAS Number: None
Molecular Formula: C₁₉H₁₇N₅O₃S
Molecular Weight: 395.43
Advantages
Well-defined with distinct functional groups: Contains benzimidazole core, 1-nitroso (-N-NO), 6-(1H-pyrrol-1-yl), and 2-(((4-methoxy-3-methylpyridin-2-yl)methyl)sulfinyl). Unlike ilaprazole (proton pump inhibitor with 1-H), its nitroso polarity, sulfinyl (-S=O) oxidation state, and polycyclic conjugation create significant differences, enabling precise differentiation via HPLC/ion-pair chromatography as a specific marker;
High stability and traceability: Rigid benzimidazole/pyridine/pyrrole structures and stability of sulfinyl/nitroso ensure stability under dark, low-temperature conditions. As a derivative from 1-amino nitrosation during storage/degradation, it directly reflects amino stability and nitrite exposure, improving impurity tracing accuracy;
High detection sensitivity: Polycyclic conjugation shows strong UV absorption (250-300nm), combined with m/z 396 [M+H]⁺ enabling ppb-level analysis via LC-MS, compatible with proton pump inhibitor nitroso impurity systems.
Applications
Pharmaceutical quality control: Used as an impurity reference standard to quantify Ilaprazole Nitroso Impurity 123 in APIs, ensuring compliance with genotoxic impurity limits in pharmaceutical standards;
Stability studies: Monitoring impurity levels under varying conditions (pH, light) to assess degradation trends and support shelf-life assurance;
Degradation pathway analysis: Identifying 1-amino nitrosation as a key degradation route to guide formulation improvements (e.g., nitrosation inhibitor addition).
Background Description
Research Status
Analytical method validation: Developing UPLC-MS/MS methods with C18 columns for separation, achieving 0.01 ppb detection limits;
Nitrosation mechanism: Studying impurity formation kinetics under varying nitrite concentration and pH to clarify 1-amino-to-nitroso conversion pathways;
Control strategies: Exploring nitrosation inhibitors (e.g., ascorbic acid) to keep impurity levels below safety limits (<0.001%);
Toxicity evaluation: Conducting in vitro genotoxicity tests (e.g., Ames, chromosome aberration) to assess potential hazards and support limit setting.
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/5mg |
VIP1Y
|
Guangzhou Tosun Pharmaceutical Ltd
|
2024-12-20 | |
| $0.00/10mg |
VIP2Y
|
ShenZhen H&D Pharmaceutical Technology Co., LTD
|
2024-04-22 | |
| $36.00/1kg |
VIP2Y
|
Henan Fengda Chemical Co., Ltd
|
2024-04-29 |

China